Literature DB >> 14212115

A COMPARISON OF THE SPECIFICITY OF INHIBITION BY PHOSPHONATE ESTERS OF THE FIRST COMPONENT OF COMPLEMENT AND THE ANTIGEN-INDUCED RELEASE OF HISTAMINE FROM GUINEA PIG LUNG.

E L BECKER, K F AUSTEN.   

Abstract

The ability of a number p-nitrophenylethyl alkyl, phenyl alkyl, chloroalkyl, and aminoalkyl phosphonates to inhibit the activated first component (C'1a) of guinea pig complement, and the antigen-induced release of histamine from sliced, perfused guinea pig lung has been compared. C'1a in its reactivity with these phosphonates is distinctly more similar to trypsin than to any of the other enzymes studied previously. It is suggested that both trypsin and C'1a possess an anionic group in the active center of the respective enzyme, but the distance between the anionic and esteratic site in C'1a might be less than in trypsin. The pattern of inhibition of histamine relase by the alkyl, phenyl alkyl, and chloroalkyl phosphonates is similar to the inhibition of C'1a by these compounds, although distinct differences are apparent. The aminoalkyl phosphonates are distinctly less active inhibitors of histamine release than the corresponding alkyl phosphonates, whereas the reverse is true of the inhibition of C'1a. On the basis of these differences, it is tentatively concluded that the organophosphorus-inhibitable enzymes in the guinea pig systems studied here are similar but not identical.

Entities:  

Keywords:  ANTIGENS; COMPLEMENT; EXPERIMENTAL LAB STUDY; GUINEA PIGS; HISTAMINE LIBERATION; LUNG; PHARMACOLOGY; PHOSPHONIC ACIDS; TRYPSIN

Mesh:

Substances:

Year:  1964        PMID: 14212115      PMCID: PMC2137770          DOI: 10.1084/jem.120.4.491

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Molecular complementarity and antidotes for alkylphosphate poisoning.

Authors:  I B WILSON
Journal:  Fed Proc       Date:  1959-07

2.  ENZYME INHIBITORY ACTIVITY OF CERTAIN PHOSPHONATE ESTERS AGAINST CHYMOTRYPSIN, TRYPSIN AND ACETYLCHOLINESTERASE.

Authors:  B J BOONE; E L BECKER; D H CANHAM
Journal:  Biochim Biophys Acta       Date:  1964-06-01

3.  CHROMATOGRAPHIC SEPARATION OF THE FIRST COMPONENT OF COMPLEMENT AND ITS ASSAY ON A MOLECULAR BASIS.

Authors:  T BORSOS; H J RAPP
Journal:  J Immunol       Date:  1963-12       Impact factor: 5.422

Review 4.  ACTIVE CENTER OF CARBOXYPEPTIDASE A.

Authors:  B L VALLEE
Journal:  Fed Proc       Date:  1964 Jan-Feb

5.  The toxic action of some phosphorus anticholinesterases with cationic groups.

Authors:  D F HEATH
Journal:  Biochem Pharmacol       Date:  1961-06       Impact factor: 5.858

6.  Inhibition of immune hemolysis by diisopropyl fluorophosphate.

Authors:  L LEVINE
Journal:  Biochim Biophys Acta       Date:  1955-10

7.  Concerning the mechanism of complement action. II. The nature of the first component of guinea pig complement.

Authors:  E L BECKER
Journal:  J Immunol       Date:  1956-12       Impact factor: 5.422

8.  The inhibition of erythrocyte cholinesterase by tri-esters of phosphoric acid. I. Diethyl p nitrophenyl phosphate (E600) and analogues.

Authors:  W N ALDRIDGE; A N DAVISON
Journal:  Biochem J       Date:  1952-04       Impact factor: 3.857

9.  Acylation of the enzymatic site of delta-chymotrypsin by esters, acid anhydrides, and acid chlorides.

Authors:  G H DIXON; H NEURATH
Journal:  J Biol Chem       Date:  1957-04       Impact factor: 5.157

10.  Anaphylaxis in chopped guinea pig lung. I. Effect of peptidase substrates and inhibitors.

Authors:  K F AUSTEN; W E BROCKLEHURST
Journal:  J Exp Med       Date:  1961-03-01       Impact factor: 14.307

View more
  10 in total

1.  Inhibition of guinea-pig complement by derivatives of benzamidine. I. Effect of p-nitrophenylureido derivative of m-(m-phenoxypropoxy)benzamidine on guinea-pig complement component haemolytic activity.

Authors:  M M Glovsky; M Cory; A Alenty
Journal:  Immunology       Date:  1974-04       Impact factor: 7.397

2.  Mode of action of disodium cromoglycate, studies on immediate type hypersensitivity reactions using 'double sensitization' with two antigenically distinct rat reagins.

Authors:  J S Cox; T S Orr; M C Pollard; J Gwilliam
Journal:  Clin Exp Immunol       Date:  1970-11       Impact factor: 4.330

3.  On the inhibitory action of DFP and PMSF on histamine release from isolated rat mast cells [proceedings].

Authors:  B Diamant; S A Patkar
Journal:  Agents Actions       Date:  1977-03

4.  Selective antigen-stimulated release of proteolytic activity from rat mast cells.

Authors:  O H Wilhelms
Journal:  Agents Actions       Date:  1980-12

5.  Mechanisms of immunologic injury of rat peritoneal mast cells. I. The effect of phosphonate inhibitors on the homocytotropic antibody-mediated histamine release and the first component of rat complement.

Authors:  E L Becker; K F Austen
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307

6.  Mechanisms of the inhibition of chemotaxis by phosphonate esters.

Authors:  P A Ward; E L Becker
Journal:  J Exp Med       Date:  1967-06-01       Impact factor: 14.307

7.  Mechanisms of immunologic injury of rat peritoneal mast cells. II. Complement requirement and phosphonate ester inhibition of release of histamine by rabbit anti-rat gamma globulin.

Authors:  K F Austen; E L Becker
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307

8.  Esterases of the polymorphonuclear leukocyte capable of hydrolyzing acetyl DL-phenyl-alanine beta-naphthyl ester. Relationship to the activatable esterase of chemotaxis.

Authors:  E L Becker; P A Ward
Journal:  J Exp Med       Date:  1969-03-01       Impact factor: 14.307

9.  Antibodies involved in antigen-induced release of slow reacting substance of anaphylaxis (SRS-A) in the guinea pig and rat.

Authors:  D J Stechschulte; K F Austen; K J Bloch
Journal:  J Exp Med       Date:  1967-01-01       Impact factor: 14.307

10.  The requirement of serine esterase function in complement-dependent erythrophagocytosis.

Authors:  D S Pearlman; P A Ward; E L Becker
Journal:  J Exp Med       Date:  1969-10-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.